Critical Issues in Alcohol and Drugs of Abuse Testing

Amitava Dasgupta received his Ph. D in chemistry from Stanford University and completed his fellowship training in Clinical Chemistry from the Department of Laboratory Medicine at the University of Washington School of Medicine at Seattle. He is board certified in both Toxicology and Clinical Chemistry by the American Board of Clinical Chemistry. Currently, he is a tenured Full Professor of Pathology and Laboratory Medicine at the University of Kansas Medical Center and Director of Clinical Laboratories at the University of Kansas Hospital. Prior to this appointment he was a tenured Professor of Pathology and Laboratory Medicine at the University of Texas McGovern medical School from February 1998 to April 2022. He has 252 papers to his credit. He is in the editorial board of four journals including Therapeutic Drug Monitoring, Clinica Chimica Acta, Archives of Pathology and Laboratory Medicine, and Journal of Clinical Laboratory Analysis.

• 1. Alcohol: Pharmacokinetics, Health Benefits with Moderate Consumption and Toxicity2. Alcohol Analysis in Various Matrixes: Clinical versus Forensic Testing3. Alcohol Biomarkers: Clinical Issues and Analytical Methods4. Genetic Markers Related to Alcohol Use and Abuse5. Ethylene Glycol and Other Glycols: Testing and Interpretation Issues6. Introduction to Drugs of Abuse7. Legal Aspects of Drug Testing in U.S. Military and Civil Courts8. Pharmacogenomics of Drugs of Abuse9. Immunoassay Design for Screening of Drugs of Abuse10. Issues of Interferences with Immunoassays used for Screening of Drugs of Abuse in Urine11. Point of Care Devices for Drugs of Abuse Testing: Limitations and Pitfalls12. Drugs of Abuse Screening and Confirmation with Lower Cutoff values13. Overview of Analytical Methods in Drugs of Abuse Analysis: Gas Chromatography/Mass Spectrometry, Liquid Chromatography Combined with Tandem Mass Spectrometry and Related Methods14. High Resolution Mass Spectrometry: An Emerging Analytical method for drug testing15. Confirmation Methods for SAMHSA Drugs and Other Commonly Abused Drugs16. Critical Issues when Testing for Amphetamine Type Stimulants: Pitfalls of Immunoassay Screening and Mass Spectrometric Confirmation for Amphetamines, Methamphetamines, and Designer Amphetamines 17. Cocaine, Crack Cocaine and Ethanol: A Deadly Mix18. Drug assisted sexual assaults: Toxicology, Fatality and Analytical Challenge19. Overview of Common Designer Drugs20. Novel Psychoactive Substances: An Overview21. Review of Bath Salts on Illicit Drug Market22. Review of Synthetic Cannabinoids on Illicit Drug Market23. Application of Liquid chromatography combined with high resolution mass spectrometry for urine drug testing24. Forensic Toxicology in Death Investigation25. Drug Testing in Pain Management26. How do people try to beat drugs test? Effects of synthetic urine, substituted urine, diluted urine and in vitro urinary adulterants on drugs of abuse testing27. When Hospital Toxicology Report is Negative in a Suspected Overdosed Patient: Strategy of Comprehensive Drug Screen using Liquid Chromatography combined with Mass Spectrometry28. Testing of Drugs in Oral Fluid, Sweat, Hair and Nail: analytical, Interpretative and Specimen Adulteration Issues29. Advances in Meconium Analysis for Assessment of Neonatal Drug Exposure30. Analytical True Positive Drug Tests Due to Use of Prescription and Non-Prescription Medications31. Analytical True Positive: Poppy Seed Products and Opiate Analysis32. Miscellaneous Issues: Paper Money contaminated with Cocaine and Other Drugs, Cocaine Containing Herbal Teas, Passive Exposure of Marijuana, Ingestion of Hemp Oil and Occupational Exposure to Controlled Substances33. Abuse of Magic Mushroom, Peyote cactus, LSD, Khat, and Volatiles34. Performance Enhancing Drugs in Sports